ONVO 1 (-2.91%)
US68620A2033Medical Diagnostics & ResearchDiagnostics & Research

Organovo Holdings (ONVO) Competitor Comparison

We are evaluating the key criteria listed to compare Organovo Holdings (ONVO) against its competitors in the Diagnostics & Research industry.

Performance 3 years - ONVO ranking 48 / 58

These are the competitors of Organovo Holdings in the industry Diagnostics & Research ranked by performance 3 years
1. Meridian Bioscience VIVO
246.63
2. Lantheus Holdings LNTH
193.65
3. RadNet RDNT
110.02
4. Medpace Holdings MEDP
106.87
5. SeqLL SQL
59.42
6. Heska HSKA
41.31
7. Icon ICLR
40.96
8. DexCom DXCM
31.83
9. PerkinElmer PKI
21.19
10. Ortho Clinical Diagnostics Holdings OCDX
13.74
11. Thermo Fisher Scientific TMO
11.18
12. IQVIA Holdings IQV
5.74
13. Agilent Technologies A
-1.23
14. Waters WAT
-1.57
15. Quest Diagnostics DGX
-1.65
16. Danaher DHR
-2.62
17. Mettler-Toledo MTD
-6.88
18. Laboratory Corp of America Holdings LH
-10.23
19. IDEXX Laboratories IDXX
-10.68
20. Anixa Biosciences ANIX
-18.54
21. Natera NTRA
-18.94
22. Syneos Health SYNH
-19.01
23. Qiagen QGEN
-23.63
24. National Research NRC
-27.67
25. Charles River Laboratories CRL
-29.56
26. Myriad Genetics MYGN
-31.81
27. Sera Prognostics SERA
-35.04
28. Olink Holding OLK
-42.07
29. Trinity Biotech TRIB
-49.3
30. Exact Sciences EXAS
-52.23
31. Sotera Health SHC
-58.09
32. Psychemedics PMD
-62.48
33. Enzo Biochem ENZ
-66.87
34. bioAffinity Technologies BIAF
-66.9
35. Neuronetics STIM
-67.07
36. Global Cord Blood CO
-67.25
37. Bioventus BVS
-70.11
38. Illumina ILMN
-70.5
39. NeoGenomics NEO
-72.1
40. Neogen NEOG
-75.43
41. MaxCyte MXCT
-76.75
42. Fulgent Genetics FLGT
-77.25
43. Twist Bioscience TWST
-78.54
44. Inotiv NOTV
-80.91
45. MDxHealth MDXH
-81.65
46. Interpace Biosciences IDXG
-82.1
47. Precipio PRPO
-83.24
48. Organovo Holdings ONVO
-86.81
49. Co-Diagnostics CODX
-87.08
50. CareDx CDNA
-88.68
51. Guardant Health GH
-89.73
52. Exagen XGN
-92.07
53. Biodesix BDSX
-93.5
54. DarioHealth DRIO
-93.64
55. Personalis PSNL
-94.12
56. Pacific Biosciences of California PACB
-94.89
57. Aspira Womens Health AWH
-96.12
58. Prenetics Global PRE
-97.58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.